About i3 Genesis

i3 Genesis is the inaugural funding program for early-stage healthcare technologies with clear potential for commercialization and with defined technology or data gaps that can be addressed with funding. Part of MSIP’s i3 Funding Series, this program aims to support and translate innovations by providing up to $50K to achieve value inflection points.

We Are Looking For:

  • Innovations with potential for commercialization and development of proof-of-concept data or prototypes.
  • A budget of up to $50K with a milestone-based development plan.
  • Research and development efforts performed by Mount Sinai only.

Proposals involving Human Subjects or Animal Research require extra steps, such as gaining formal approval from the Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC).

i3 Genesis Timeline

  • January to March 4:
    RFP submission period
  • Late April:
    RFP submission deadline
  • May:
    Teams chosen to present to judging panel
  • June:
    Presentations to judging panel
  • Late June:
    Funding decisions communicated to teams
  • July:
    Sign Informed Participation Letter; finalize plans and budget
  • Late July:
    Project execution begins

How to Apply

The RFP period is closed. Please check this web page for updates.

Contact Us

For more information, please reach out to Louise Lammers, PhD, Director of Business Development, Emerging Assets at louise.lammers@mssm.edu or William Chiang, PhD, Business Development Consultant, at william.chiang@mssm.edu.